Downtrend Call Working As Amarin Stock Falls 16.0% (AMRN)
SmarTrend identified a Downtrend for Amarin (NASDAQ:AMRN) on December 7th, 2012 at $9.65. In approximately 3 months, Amarin has returned 16.02% as of today's recent price of $8.10.
Over the past year, Amarin has traded in a range of $7.01 to $15.96 and is now at $8.10, 16% above that low. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.8% while the 200-day MA has slid 0.5%.
Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Amarin.
Log in and add Amarin (AMRN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Keywords: spotlights amarin